IVE Group (ASX:IGL) FY22 H1 results
01 Mar 2022 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the highlights of the company's recently released results, key drivers and outlook.
01 Mar 2022 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the highlights of the company's recently released results, key drivers and outlook.
28 Feb 2022 - BHP Group Limited (ASX:BHP) CEO Mike Henry and CFO David Lamont provide a shareholder update with Gabrielle Notley, Head of Corporate Communications.
24 Feb 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the sectors to invest in given slowing global growth, tightening financial conditions, the risk of inflation and geopolitical imbalances.
15 Feb 2022 - Imdex (ASX:IMD) CEO Paul House discusses drivers behind the company's 1H22 performance, research and development, and outlook.
17 Jan 2022 - eCargo Holdings Limited (ASX:ECG) Head of Corporate Marketing Lewis Bacon provides an insight into how eCommerce will continue to grow in China and across Asia, and eCargo’s position to assist brands with market entry.
16 Dec 2021 - Magnetite Mines Limited (ASX:MGT) Technical Director Mark Eames discusses the global move towards low-emission steel and the implications for Australia's iron ore exports.
14 Dec 2021 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's $2.7m share placement, as well as recent deals with NEC and Panasonic.
08 Dec 2021 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the cracking of the "silicon barrier" in order to significantly increase the energy retention and capacity of lithium-ion batteries for electric vehicles.
01 Dec 2021 - MinRex Resources Limited (ASX:MRR) Non-Executive Director George Karageorge provides an update on the company's gold and base metals projects in WA and the Lachlan Ford Belt, NSW and its recently acquired lithium projects in the Pilbara.
30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.